| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Division of Thoracic Surgery [G. J. G., W. G. R., D. J. S., R. B.], and Renal Division, Department of Medicine, [L-L. H.], Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 02115; Department of Physics, Wesleyan University, Middletown, Connecticut 06457 [R. V. J., J. E. B.]; Department of Neurology, Brigham and Womens Hospital, Harvard Medical School, Cambridge, Massachusetts 02139 [S. R. G.]; Department of Adult Oncology, Dana-Farber Cancer Institute [S. R.], Harvard Medical School, Boston, Massachusetts 02115; and Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, Cambridge, Massachusetts 02139 [S. R.]
The pathological distinction between malignant pleural mesothelioma (MPM)and adenocarcinoma (ADCA) of the lung can be cumbersome using established methods. We propose that a simple technique, based on the expression levels of a small number of genes, can be useful in the early and accurate diagnosis of MPM and lung cancer. This method is designed to accurately distinguish between genetically disparate tissues using gene expression ratios and rationally chosen thresholds. Here we have tested the fidelity of ratio-based diagnosis in differentiating between MPM and lung cancer in 181 tissue samples (31 MPM and 150 ADCA). A training set of 32 samples (16 MPM and 16 ADCA) was used to identify pairs of genes with highly significant, inversely correlated expression levels to form a total of 15 diagnostic ratios using expression profiling data. Any single ratio of the 15 examined was at least 90% accurate in predicting diagnosis for the remaining 149 samples (e.g., test set). We then examined (in the test set) the accuracy of multiple ratios combined to form a simple diagnostic tool. Using two and three expression ratios, we found that the differential diagnoses of MPM and lung ADCA were 95% and 99% accurate, respectively. We propose that using gene expression ratios is an accurate and inexpensive technique with direct clinical applicability for distinguishing between MPM and lung cancer. Furthermore, we provide evidence suggesting that this technique can be equally accurate in other clinical scenarios.
This article has been cited by other articles:
![]() |
B. C. Christensen, C. J. Marsit, E. A. Houseman, J. J. Godleski, J. L. Longacker, S. Zheng, R.-F. Yeh, M. R. Wrensch, J. L. Wiemels, M. R. Karagas, et al. Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles Cancer Res., August 1, 2009; 69(15): 6315 - 6321. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, L. Dong, B. Y. Yeap, W. G. Richards, J. N. Glickman, H. Edenfield, M. Mani, R. Colquitt, G. Maulik, B. Van Oss, et al. Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma J Natl Cancer Inst, May 6, 2009; 101(9): 678 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., April 15, 2009; 15(8): 2850 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-S. Lee, D.-S. Son, S.-H. Kim, J. Lee, J. Jo, J. Han, H. Kim, H. J. Lee, H. Y. Choi, Y. Jung, et al. Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression Clin. Cancer Res., November 15, 2008; 14(22): 7397 - 7404. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Sugarbaker, W. G. Richards, G. J. Gordon, L. Dong, A. De Rienzo, G. Maulik, J. N. Glickman, L. R. Chirieac, M.-L. Hartman, B. E. Taillon, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors PNAS, March 4, 2008; 105(9): 3521 - 3526. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reed, A. Graham, R. S. Hoda, A. Khoor, E. Garrett-Mayer, M. B. Wallace, and M. Mitas A simple two-gene prognostic model for adenocarcinoma of the lung J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tai and W. Pan Incorporating prior knowledge of gene functional groups into regularized discriminant analysis of microarray data Bioinformatics, December 1, 2007; 23(23): 3170 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vachani, M. Nebozhyn, S. Singhal, L. Alila, E. Wakeam, R. Muschel, C. A. Powell, P. Gaffney, B. Singh, M. S. Brose, et al. A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma Clin. Cancer Res., May 15, 2007; 13(10): 2905 - 2915. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gaines, R. M.-D. Wilke, P. P Pun, and G. Gordon Applicability of cDNA and Oligonucleotide Microarray to a Diagnostic Test of Human Disease using Gene Expression Ratios FASEB J, April 1, 2007; 21(6): A750 - A750. |
||||
![]() |
A. Schramm, J. Vandesompele, J. H. Schulte, S. Dreesmann, L. Kaderali, B. Brors, R. Eils, F. Speleman, and A. Eggert Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome Clin. Cancer Res., March 1, 2007; 13(5): 1459 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Chen, S.-L. Yu, C.-H. Chen, G.-C. Chang, C.-Y. Chen, A. Yuan, C.-L. Cheng, C.-H. Wang, H.-J. Terng, S.-F. Kao, et al. A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer N. Engl. J. Med., January 4, 2007; 356(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Tyszko, G. D. Marano, R. J. Tallaksen, and K. A. Gyure Best Cases from the AFIP: Malignant Mesothelioma RadioGraphics, January 1, 2007; 27(1): 259 - 264. [Full Text] [PDF] |
||||
![]() |
J. Z. Kelemen, A. Kertesz-Farkas, A. Kocsor, and L. G. Puskas Kalman filtering for disease-state estimation from microarray data Bioinformatics, December 15, 2006; 22(24): 3047 - 3053. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, L. A. Deters, M. D. Nitz, B. C. Lieberman, B. Y. Yeap, and R. Bueno Differential diagnosis of solitary lung nodules with gene expression ratios J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Liu, W.-S. E. Chen, C.-C. Lin, H.-C. Liu, H.-Y. Chen, P.-C. Yang, P.-C. Chang, and J. J.W. Chen Topology-based cancer classification and related pathway mining using microarray data Nucleic Acids Res., September 1, 2006; 34(14): 4069 - 4080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Holloway, D. S. Diyagama, K. Opeskin, J. Creaney, B. W.S. Robinson, R. A. Lake, and D. D.L. Bowtell A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions Clin. Cancer Res., September 1, 2006; 12(17): 5129 - 5135. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guo, Y. Ma, R. Ward, V. Castranova, X. Shi, and Y. Qian Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma. Clin. Cancer Res., June 1, 2006; 12(11): 3344 - 3354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nebozhyn, A. Loboda, L. Kari, A. H. Rook, E. C. Vonderheid, S. Lessin, C. Berger, R. Edelson, C. Nichols, M. Yousef, et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy Blood, April 15, 2006; 107(8): 3189 - 3196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Tan, D. Q. Naiman, L. Xu, R. L. Winslow, and D. Geman Simple decision rules for classifying human cancers from gene expression profiles Bioinformatics, October 15, 2005; 21(20): 3896 - 3904. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Robinson and R. A. Lake Advances in malignant mesothelioma. N. Engl. J. Med., October 13, 2005; 353(15): 1591 - 1603. [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, G. N. Rockwell, P. A. Godfrey, R. V. Jensen, J. N. Glickman, B. Y. Yeap, W. G. Richards, D. J. Sugarbaker, and R. Bueno Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma Clin. Cancer Res., June 15, 2005; 11(12): 4406 - 4414. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, G. N. Rockwell, R. V. Jensen, J. G. Rheinwald, J. N. Glickman, J. P. Aronson, B. J. Pottorf, M. D. Nitz, W. G. Richards, D. J. Sugarbaker, et al. Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling Am. J. Pathol., June 1, 2005; 166(6): 1827 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, F. S. Makedon, J. C. Ford, and J. Pearlman HykGene: a hybrid approach for selecting marker genes for phenotype classification using microarray gene expression data Bioinformatics, April 15, 2005; 21(8): 1530 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Granville and P. A. Dennis An Overview of Lung Cancer Genomics and Proteomics Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cesario, A. Catassi, L. Festi, A. Imperatori, A. Pericelli, D. Galetta, S. Margaritora, V. Porziella, V. Cardaci, P. Granone, et al. Farnesyltransferase Inhibitors and Human Malignant Pleural Mesothelioma: A First-Step Comparative Translational Study Clin. Cancer Res., March 1, 2005; 11(5): 2026 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Michael and M.M. Doherty Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy J. Clin. Oncol., January 1, 2005; 23(1): 205 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kettunen, A.G. Nicholson, B. Nagy, H. Wikman, J.K. Seppanen, T. Stjernvall, T. Ollikainen, V. Kinnula, S. Nordling, J. Hollmen, et al. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray Carcinogenesis, January 1, 2005; 26(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bueno, J. Reblando, J. Glickman, M. T. Jaklitsch, J. M. Lukanich, and D. J. Sugarbaker Pleural Biopsy: A Reliable Method for Determining the Diagnosis But Not Subtype in Mesothelioma Ann. Thorac. Surg., November 1, 2004; 78(5): 1774 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mikawa, H. Wang, L. Guo, R. Liu, J. Marik, Y. Takada, K. Lam, and D. Lau Novel peptide ligands for integrin {alpha}4{beta}1 overexpressed in cancer cells Mol. Cancer Ther., October 1, 2004; 3(10): 1329 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Hoang, J. D'Cunha, M. G. Kratzke, C. E. Casmey, S. P. Frizelle, M. A. Maddaus, and R. A. Kratzke Gene Expression Profiling Identifies Matriptase Overexpression in Malignant Mesothelioma Chest, May 1, 2004; 125(5): 1843 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaminski and M. Krupsky Gene Expression Patterns, Prognostic and Diagnostic Markers, and Lung Cancer Biology Chest, May 1, 2004; 125(5_suppl): 111S - 115S. [Full Text] [PDF] |
||||
![]() |
H. I. Pass, Z. Liu, A. Wali, R. Bueno, S. Land, D. Lott, F. Siddiq, F. Lonardo, M. Carbone, and S. Draghici Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma Clin. Cancer Res., February 1, 2004; 10(3): 849 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, W. G. Richards, D. J. Sugarbaker, M. T. Jaklitsch, and R. Bueno A Prognostic Test for Adenocarcinoma of the Lung From Gene Expression Profiling Data Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 905 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Singhal, R. Wiewrodt, L. D. Malden, K. M. Amin, K. Matzie, J. Friedberg, J. C. Kucharczuk, L. A. Litzky, S. W. Johnson, L. R. Kaiser, et al. Gene Expression Profiling of Malignant Mesothelioma Clin. Cancer Res., August 1, 2003; 9(8): 3080 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, R. V. Jensen, L.-L. Hsiao, S. R. Gullans, J. E. Blumenstock, W. G. Richards, M. T. Jaklitsch, D. J. Sugarbaker, and R. Bueno Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma J Natl Cancer Inst, April 16, 2003; 95(8): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Hofmann, G. Hansen, S. Burdach, B. Bartling, R.-E. Silber, and A. Simm Discrimination of Human Lung Neoplasm from Normal Lung by Two Target Genes Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 516 - 519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |